Business Wire

EH-GROUP

Share
EH Group Establishes Innovation Lab in India

EH Group is expanding its footprint by establishing an Innovation Lab in India, based at the IITM Research Park. Recently established EH Group Systems Pvt Ltd, is aimed at accelerating the development of our fuel cell products, primarily focusing on our proprietary control systems software.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230111005413/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

EH Group Innovation Lab at IIT Madras Research Park (Photo: Business Wire)

It is led by Anand Vasappanavara, Principal Control/Automation engineer, who was instrumental in designing FC system control development programs at major OEMs before joining EH Group in 2019. He is supported by a pre-established team that have already been collaborating with us, as well as several additional hires, notably from the strong academic talent pool at IIT Madras. We expect our team to grow rapidly to meet the nascent market opportunity.

India is demonstrating its ambition to be a leader in hydrogen technologies, as witnessed by strong policy support and industrial investment announcements. Our goal is not only to support our fuel cell technology development but to better service our clients in the rapidly growing hydrogen sector in India” says Mardit Matian, founder of EH Group.

The time has never been better to invest in the hydrogen ecosystem in India. We are excited to benefit from its deep talent pool and to accelerate India’s journey towards decarbonisation and greater energy independence. ”, added Christopher Brandon, co-founder.

EH Group – Headquartered in Nyon, Switzerland since 2017. It is focused on the design and production of its innovative fuel cell technology, to decarbonise heavy duty mobility and large scale stationary applications. It offers high power density fuel cell stacks with greater efficiencies and a unique production process that radically reduces costs with scale.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005413/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Positive CHMP Opinion for the Extension of Indication of Palforzia® for the Treatment of Toddlers With Confirmed Peanut Allergy2.12.2024 09:30:00 CET | Press release

Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) provided a positive opinion for the extension of the existing indication for Palforzia® (defatted powder of Arachis hypogaea L., semen (peanuts))to the treatment of toddlers (ages 1 to 3) with a confirmed diagnosis of peanut allergy. If the extension indication is granted by the European Commission, Palforzia® will become the first EMA approved oral immunotherapy (OIT) treatment for toddlers living with confirmed peanut allergy. Palforzia® is designed to gradually increase the body’s ability to tolerate small amounts of peanut (desensitisation) through carefully controlled and supervised initial dose escalation, up-dosing and maintenance. The extension of the indication, with adjustment of contraindications, would enable treatment to be initiated at an earlier age, thus offerin

Digita Selects Netmore Platform-as-a-Service to Scale LoRaWAN®-based IoT Network Capabilities in Finland2.12.2024 08:00:00 CET | Press release

Digita and Netmore to Jointly Develop Large-Scale Projects in Utility, Building, Construction, and Logistics Verticals Netmore Group, a leading global LoRaWAN network operator, today announced that Digita, a Finnish technology company specializing in broadcast networks and telecom services, has selected Netmore’s Operator Platform-as-a-Service (PaaS) to expand, optimize, and scale its LoRaWAN network capabilities for the delivery of Internet of Things (IoT) applications in Finland. The leading domestic network operator, Digita offers a complete infrastructure for IoT services including a nationwide public LoRaWAN network and private network build outs based on customer needs. With an extensive and growing base of digital transformation deployments across the utility, district heating, smart building, and logistics verticals, Digita selected Netmore’s PaaS offering to reduce the number of systems needed to deliver IoT connectivity to its customers. In addition to streamlining its operat

Bureau Veritas completes the acquisition of The APP Group, strengthening its Buildings & Infrastructure leadership position in Asia-Pacific2.12.2024 07:30:00 CET | Press release

Bureau Veritas, a global leader in Testing, Inspection, and Certification services, today announced that it has completed the acquisition of The APP Group, a leading Australian Property and Infrastructure leader, as stated in its communication to the market on November 4th, 2024. The company is headquartered in Sydney and delivered revenues of €87 million in 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241201814044/en/ Hinda Gharbi, CEO Bureau Veritas (Photo: Business Wire) This acquisition is in line with Bureau Veritas’ LEAP | 28 strategy to expand leadership in Buildings and Infrastructure, diversifying its portfolio and investing in an attractive regional market. It will strengthen the Group’s Buildings and Infrastructure capabilities by adding significant project management assistance expertise to asset owners, as well as construction management, independent project verification and certification and benefiting

PQ Expands Nordic Presence with Acquisition of Sibelco's Specialty Silicate Business2.12.2024 06:00:00 CET | Press release

PQ (www.pqcorp.com), a leading global producer of silicates, silicas and derivative products, announced that it has agreed to acquire the specialty silicate business of the Sibelco Group currently operated in the Lödöse plant in Sweden. “Sibelco’s silicate business has a long history of success in Sweden,” said Al Beninati, CEO of PQ. “This acquisition allows PQ to expand our sodium and potassium silicate offerings to the Nordic markets such as mining, construction, and pulp & paper. PQ has operated in the region for over 70 years and looks forward to continuing to provide high-quality products as part of this expanded portfolio.” Completion of the acquisition is subject to customary regulatory approvals and is expected early 2025. About PQ With headquarters in Malvern, Pennsylvania PQ is a leading global provider of silicates, silicas and derivative products. PQ’s products are found in a wide variety of industries and many aspects of everyday life, from decorative paints to green ceme

GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical2.12.2024 05:45:00 CET | Press release

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Acquisition positions NMP to become partner of choice for global innovators looking to bring novel radiopharmaceuticals to Japan and other Asian markets Transaction bolsters GE HealthCare’s Pharmaceutical Diagnostics segment and demonstrates its commitment to shaping the future of Molecular Imaging GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from Sumitomo Chemical (TYO: 4005) the 50% stake it does not already own. As part of GE HealthCare, NMP can build on its expertise developing and manufacturing proprietary and in-licensed radiopharmaceuticals used in single photon emission computed tomograp

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye